Characterization of novel Staphylococcus aureus lytic phage and defining their combinatorial virulence using the

Luis A Estrella1, Javier Quinones1, Matthew Henry1

  • 1Biological Defense Research Directorate, Naval Medical Research Center-Frederick , Fort Detrick, MD USA.

Bacteriophage
|October 15, 2016
PubMed

Insights

Novel bacteriophages (phages) show promise for treating antibiotic-resistant Staphylococcus aureus infections. A combination of phages effectively reduces bacterial growth and prevents resistance, offering a potential new therapy for skin infections.

Area of Science:

  • Microbiology
  • Virology
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) causes difficult-to-treat skin and soft tissue infections (SSTIs).
  • Bacteriophages (phages) are viruses that infect bacteria and are being explored as an alternative to antibiotics for resistant infections.

Purpose of the Study:

  • To isolate and characterize novel bacteriophages with lytic activity against Staphylococcus aureus, including MRSA.
  • To evaluate the efficacy of these novel phages, individually and in combination, against clinical isolates of S. aureus.
  • To investigate the potential of phage combinations to overcome phage resistance.

Main Methods:

  • Isolation and identification of seven novel phages with broad lytic activity against S. aureus.
  • Efficiency of plating (EOP) assays to screen 170 clinical isolates (MRSA and MSSA).
  • Electron microscopy for phage morphology, restriction endonuclease analysis for genetic relatedness, and OmniLog® microplate assay for growth rate and synergy studies.

Main Results:

  • The novel phages demonstrated virulent lytic activity, inhibiting 70-91% of MRSA and MSSA isolates.
  • Phages belong to the Myoviridae family and require specific cell wall components for infection.
  • Combinations of phage K with novel phages (SA0420ᶲ1, SA0456ᶲ1, SA0482ᶲ1) exhibited synergistic lytic effects and suppressed the emergence of phage resistance.

Conclusions:

  • A broad-spectrum lytic phage mixture effectively combats S. aureus, including resistant strains.
  • Phage combinations can suppress the development of bacterial resistance, a significant challenge in phage therapy.
  • These findings highlight the potential of phage therapy for treating S. aureus wound infections.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
79.4K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
69.0K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.2K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.1K
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.3K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
832